First Western Trust Bank Has $4.34 Million Position in Danaher Corporation (NYSE:DHR)

Key Points

• First Western Trust Bank reduced its holdings in Danaher Corporation by 9.7%, selling 2,284 shares, bringing its total ownership to 21,170 shares valued at approximately $4.34 million.
• Danaher reported a quarterly EPS of $1.80, exceeding analysts' estimates of $1.64, with a revenue of $5.94 billion for the quarter.
• Recent analyst ratings show a consensus rating of "Moderate Buy" for Danaher, with the consensus target price set at $247.61.

First Western Trust Bank decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 9.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,170 shares of the conglomerate's stock after selling 2,284 shares during the period. First Western Trust Bank's holdings in Danaher were worth $4,340,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Zions Bancorporation National Association UT purchased a new stake in Danaher during the 1st quarter worth about $667,000. National Bank of Canada FI boosted its position in shares of Danaher by 54.3% during the 1st quarter. National Bank of Canada FI now owns 628,625 shares of the conglomerate's stock worth $128,864,000 after acquiring an additional 221,287 shares in the last quarter. Hirtle Callaghan & Co LLC acquired a new stake in shares of Danaher during the 1st quarter worth about $1,078,000. AMF Tjanstepension AB lifted its stake in Danaher by 707.0% during the first quarter. AMF Tjanstepension AB now owns 171,931 shares of the conglomerate's stock worth $35,253,000 after purchasing an additional 150,627 shares during the last quarter. Finally, AlphaCore Capital LLC increased its stake in Danaher by 168.9% in the first quarter. AlphaCore Capital LLC now owns 9,766 shares of the conglomerate's stock valued at $2,002,000 after purchasing an additional 6,134 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Evercore ISI dropped their target price on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Jefferies Financial Group dropped their price target on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Barclays restated an "overweight" rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Argus reduced their target price on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Danaher Stock Performance

NYSE DHR traded up $2.09 during midday trading on Wednesday, hitting $207.81. The company had a trading volume of 1,635,952 shares, compared to its average volume of 4,252,766. The firm has a fifty day simple moving average of $198.95 and a two-hundred day simple moving average of $200.34. The stock has a market cap of $148.80 billion, a price-to-earnings ratio of 44.17, a P/E/G ratio of 2.79 and a beta of 0.73. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.72 earnings per share. Equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.